© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Alpha Teknova, Inc. (TKNO) stock surged +0.88%, trading at $2.28 on NASDAQ, up from the previous close of $2.26. The stock opened at $2.26, fluctuating between $2.26 and $2.39 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 26, 2026 | 2.26 | 2.40 | 2.24 | 2.28 | 172.14K |
| Feb 25, 2026 | 2.30 | 2.34 | 2.18 | 2.26 | 76.52K |
| Feb 24, 2026 | 2.09 | 2.29 | 2.08 | 2.26 | 229.76K |
| Feb 23, 2026 | 2.00 | 2.12 | 1.94 | 2.06 | 186.9K |
| Feb 20, 2026 | 2.08 | 2.14 | 2.02 | 2.06 | 149.73K |
| Feb 19, 2026 | 2.01 | 2.09 | 1.98 | 2.09 | 108.67K |
| Feb 18, 2026 | 1.99 | 2.10 | 1.99 | 2.03 | 199.57K |
| Feb 17, 2026 | 2.00 | 2.12 | 1.91 | 1.99 | 204.12K |
| Feb 13, 2026 | 2.13 | 2.23 | 1.98 | 2.00 | 123.82K |
| Feb 12, 2026 | 2.11 | 2.26 | 1.91 | 2.13 | 320.73K |
| Feb 11, 2026 | 2.12 | 2.17 | 1.91 | 2.11 | 412.97K |
| Feb 10, 2026 | 2.16 | 2.18 | 2.00 | 2.09 | 468.79K |
| Feb 09, 2026 | 2.23 | 2.26 | 1.96 | 2.16 | 694.11K |
| Feb 06, 2026 | 2.30 | 2.54 | 2.20 | 2.25 | 611.56K |
| Feb 05, 2026 | 2.26 | 2.31 | 2.17 | 2.30 | 437.08K |
| Feb 04, 2026 | 2.40 | 2.46 | 2.20 | 2.30 | 443.95K |
| Feb 03, 2026 | 2.37 | 2.50 | 2.15 | 2.44 | 488.69K |
| Feb 02, 2026 | 2.40 | 2.49 | 2.23 | 2.37 | 611.39K |
| Jan 30, 2026 | 2.82 | 2.84 | 2.29 | 2.42 | 965.43K |
| Jan 29, 2026 | 2.92 | 2.94 | 2.75 | 2.84 | 176.39K |
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
| Employees | 173 |
| Beta | 0.41 |
| Sales or Revenue | $36.68M |
| 5Y Sales Change% | 0.498% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |